Latest APLS reports update at 2024-05-07: 2024-Q12023-Q42023-Q1
Apellis Pharmaceuticals logo
Apellis Pharmaceuticals APLS
$ 42.52 0.52%

Apellis Pharmaceuticals Interest Expense 2011-2024 | APLS

Annual Interest Expense Apellis Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-727 K -288 K 1.36 M -501 K -175 K -25 K -142 K 22.4 K - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.36 M -727 K -59.2 K

Quarterly Interest Expense Apellis Pharmaceuticals

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-499 K - -603 K -63 K -277 K - 99 K 149 K -289 K - -117 K -61 K 1.54 M - -16 K 5 K 14 K - -61 K 228 K -253 K - -22.2 K -32.9 K -31.5 K - -801 397 - - 23.6 K - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
1.54 M -603 K -12 K